Celsius (NASDAQ:CELH) Price Target Raised to $110.00 at Maxim Group

Celsius (NASDAQ:CELHGet Free Report) had its target price upped by analysts at Maxim Group from $100.00 to $110.00 in a report issued on Monday, Briefing.com reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target would suggest a potential upside of 32.66% from the company’s previous close.

Other analysts have also issued research reports about the company. Bank of America lowered Celsius from a “buy” rating to a “neutral” rating and set a $65.00 target price for the company. in a report on Friday, January 19th. Jefferies Financial Group lifted their target price on Celsius from $98.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, March 18th. Stifel Nicolaus lifted their target price on Celsius from $67.00 to $90.00 and gave the stock a “buy” rating in a report on Friday, March 1st. Piper Sandler lifted their price objective on Celsius from $76.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, March 1st. Finally, Stifel Europe lifted their price objective on Celsius from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 18th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.10.

View Our Latest Stock Analysis on CELH

Celsius Trading Down 0.6 %

Shares of NASDAQ:CELH opened at $82.92 on Monday. The stock has a fifty day simple moving average of $71.49 and a two-hundred day simple moving average of $62.30. The stock has a market capitalization of $19.16 billion, a price-to-earnings ratio of 107.23, a PEG ratio of 2.42 and a beta of 1.86. Celsius has a 12-month low of $28.08 and a 12-month high of $99.62.

Celsius (NASDAQ:CELHGet Free Report) last posted its earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The business had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The company’s quarterly revenue was up 95.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.01 EPS. As a group, equities research analysts predict that Celsius will post 1.09 EPS for the current year.

Insider Buying and Selling at Celsius

In other news, CFO Jarrod Langhans sold 2,401 shares of the firm’s stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $56.72, for a total value of $136,184.72. Following the completion of the sale, the chief financial officer now directly owns 82,046 shares of the company’s stock, valued at approximately $4,653,649.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the sale, the director now directly owns 37,891 shares in the company, valued at $3,590,930.07. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Jarrod Langhans sold 2,401 shares of the stock in a transaction that occurred on Wednesday, January 3rd. The stock was sold at an average price of $56.72, for a total value of $136,184.72. Following the completion of the sale, the chief financial officer now owns 82,046 shares in the company, valued at $4,653,649.12. The disclosure for this sale can be found here. Insiders have sold a total of 1,120,568 shares of company stock worth $64,473,782 over the last ninety days. Company insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its position in Celsius by 20.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 5,908 shares of the company’s stock valued at $326,000 after acquiring an additional 1,023 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Celsius by 8.5% in the 1st quarter. JPMorgan Chase & Co. now owns 54,953 shares of the company’s stock worth $3,033,000 after purchasing an additional 4,285 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in shares of Celsius by 4.3% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 9,583 shares of the company’s stock worth $529,000 after purchasing an additional 398 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Celsius by 1.9% in the 1st quarter. Bank of New York Mellon Corp now owns 394,530 shares of the company’s stock worth $21,771,000 after purchasing an additional 7,411 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its position in shares of Celsius by 53.1% in the 1st quarter. MetLife Investment Management LLC now owns 28,662 shares of the company’s stock worth $1,582,000 after purchasing an additional 9,946 shares in the last quarter. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Company Profile

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Read More

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.